Cargando…
Mepolizumab therapy improves endomyocarditis in seropositive eosinophilic granulomatosis with polyangiitis
Autores principales: | Wang, Chrong-Reen, Tsai, Yi-Shan, Lee, Cheng-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208624/ https://www.ncbi.nlm.nih.gov/pubmed/37235127 http://dx.doi.org/10.46497/ArchRheumatol.2023.9559 |
Ejemplares similares
-
B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis
por: Wang, Chrong-Reen, et al.
Publicado: (2021) -
Multiple brain infarctions and endomyocarditis in ANCA-negative eosinophilic granulomatosis with polyangiitis
por: Tashiro, Takumi, et al.
Publicado: (2023) -
Mepolizumab therapy in a pediatric patient with eosinophilic granulomatosis with polyangiitis associated with refractory myocarditis
por: Ulu, Kadir, et al.
Publicado: (2022) -
Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
por: Pradhan, Ravi Ranjan, et al.
Publicado: (2019) -
Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
por: Condreay, Lynn D., et al.
Publicado: (2020)